Breast Breaking News

CancerVIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER22/ PIK3CA Wild-Type Advanced Breast Cancer

Is Lobular Histology a Predictor of Sentinel Node Positivity in Early Breast Cancer? An Integrated Analysis of Histological Subtype and Preoperative Imaging

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With orWithout Palbociclib in Hormone Receptor–Positive/HER22/PIK3CA Wild-Type Advanced Breast Cancer

Diagnostic accuracy of FDG-PET-CT to predictaxillary lymph node response after neoadjuvant chemotherapy in lymph nodepositive breast cancer patients

Extended Endocrine Therapy Following 5 Years of AdjuvantLuteinizing Hormone-Releasing Hormone Agonist inPremenopausal Patients With Node-Positive, HormoneReceptor–Positive Breast Cancer: A Cohort Study

Germline Pathogenic Variants AmongWomenWithout a History of Breast Cancer A Secondary Analysis of the WISDOM Randomized Clinical Trial

Pooled analysis by best confirmed response to trastuzumab deruxtecan andrelated biomarkers in patients with HER2-positive metastatic breast cancerfrom DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03

Impact of neoadjuvant immunotherapy on postoperative complications inoncoplastic breast cancer surgery